SG10201802316VA - Protein purification - Google Patents
Protein purificationInfo
- Publication number
- SG10201802316VA SG10201802316VA SG10201802316VA SG10201802316VA SG10201802316VA SG 10201802316V A SG10201802316V A SG 10201802316VA SG 10201802316V A SG10201802316V A SG 10201802316VA SG 10201802316V A SG10201802316V A SG 10201802316VA SG 10201802316V A SG10201802316V A SG 10201802316VA
- Authority
- SG
- Singapore
- Prior art keywords
- protein purification
- purification
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
- C07K1/306—Extraction; Separation; Purification by precipitation by crystallization
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1012603.5A GB201012603D0 (en) | 2010-07-27 | 2010-07-27 | Protein purification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201802316VA true SG10201802316VA (en) | 2018-04-27 |
Family
ID=42752872
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201802316VA SG10201802316VA (en) | 2010-07-27 | 2011-07-26 | Protein purification |
| SG2013001060A SG186957A1 (en) | 2010-07-27 | 2011-07-26 | Protein purification |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013001060A SG186957A1 (en) | 2010-07-27 | 2011-07-26 | Protein purification |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US9309280B2 (en) |
| EP (2) | EP3747893A1 (en) |
| JP (1) | JP5893622B2 (en) |
| KR (1) | KR101921767B1 (en) |
| CN (2) | CN107793477A (en) |
| AU (1) | AU2011284896B2 (en) |
| BR (1) | BR112013000623B1 (en) |
| CA (1) | CA2805132C (en) |
| CY (1) | CY1123619T1 (en) |
| DK (1) | DK2598514T3 (en) |
| ES (1) | ES2834967T3 (en) |
| GB (1) | GB201012603D0 (en) |
| HK (1) | HK1246330A1 (en) |
| HU (1) | HUE052159T2 (en) |
| IL (1) | IL223931A (en) |
| LT (1) | LT2598514T (en) |
| PL (1) | PL2598514T3 (en) |
| PT (1) | PT2598514T (en) |
| RS (1) | RS61095B1 (en) |
| SG (2) | SG10201802316VA (en) |
| SI (1) | SI2598514T1 (en) |
| WO (1) | WO2012013682A2 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201012603D0 (en) * | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Protein purification |
| US10228312B2 (en) | 2012-02-23 | 2019-03-12 | Juno Therapeutics Gmbh | Chromatographic isolation of cells and other complex biological materials |
| SG10201701224UA (en) * | 2012-03-12 | 2017-04-27 | Merck Patent Gmbh | Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode |
| LT2864346T (en) * | 2012-06-21 | 2019-01-25 | Synthon Biopharmaceuticals B.V. | Method of purifying an antibody |
| BR112015015948B1 (en) * | 2013-01-09 | 2022-05-17 | Takeda Pharmaceutical Company Limited | METHOD OF PURIFICATION OF RECOMBINANT ARYLSULPHATASE A (ASA) PROTEIN |
| MX368142B (en) * | 2013-04-30 | 2019-09-20 | Intas Pharmaceuticals Ltd | Novel cloning, expression & purification method for the preparation of ranibizumab. |
| CN110054661A (en) | 2013-12-12 | 2019-07-26 | Emd密理博公司 | Use the filter protein isolate containing acrylamide |
| SG11201704841UA (en) | 2014-12-22 | 2017-07-28 | Ucb Biopharma Sprl | Method of protein manufacture |
| IL282614B2 (en) | 2015-02-06 | 2024-02-01 | Cell Idx Inc | Antigen-coupled immunoreagents |
| AU2016341527B2 (en) | 2015-10-22 | 2023-04-27 | Juno Therapeutics Gmbh | Methods, kits, agents and apparatuses for transduction |
| MA45489A (en) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | CELL CULTURE PROCESSES, ASSOCIATED KITS AND APPARATUS |
| GB201602938D0 (en) | 2016-02-19 | 2016-04-06 | Ucb Biopharma Sprl | Protein purification |
| AU2017298299A1 (en) * | 2016-07-18 | 2019-02-28 | Cell Idx, Inc. | Antigen-coupled hybridization reagents |
| EP3615653A1 (en) | 2017-04-27 | 2020-03-04 | Juno Therapeutics GmbH | Oligomeric particle reagents and methods of use thereof |
| US10717023B1 (en) * | 2017-10-11 | 2020-07-21 | Roddy Kevin Stafford | Method for continuous purification |
| CN110241012B (en) * | 2018-03-09 | 2022-11-01 | 嘉和生物药业有限公司 | Production method and production module for upstream staged interception of biomacromolecules and application of production module in production |
| WO2021176311A1 (en) * | 2020-03-05 | 2021-09-10 | Lupin Limited | An improved purification process for ranibizumab |
| JP2024537490A (en) | 2021-10-27 | 2024-10-10 | プラズマ テクノロジーズ エルエルシー | Compositions and methods for isolating proteins |
| AU2023281650A1 (en) | 2022-05-30 | 2024-10-17 | Hanall Biopharma Co., Ltd. | Anti-fcrn antibody or antigen binding fragment thereof with improved stability |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5118796A (en) * | 1987-12-09 | 1992-06-02 | Centocor, Incorporated | Efficient large-scale purification of immunoglobulins and derivatives |
| US5655866A (en) | 1995-03-20 | 1997-08-12 | Bellanca; Joseph V. | Method of folding a signature for use in bookbinding |
| PT950067E (en) | 1996-11-27 | 2007-12-06 | Genentech Inc | Affinity purification of polypeptide on protein a matrix |
| AU1685499A (en) * | 1997-12-24 | 1999-07-19 | Takeda Chemical Industries Ltd. | Polypeptide, their production and use |
| ES2261589T3 (en) | 1998-05-06 | 2006-11-16 | Genentech, Inc. | ANTI-HER2 ANTIBODY COMPOSITION. |
| GB0013810D0 (en) * | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| KR100788093B1 (en) * | 2002-04-26 | 2007-12-21 | 제넨테크, 인크. | Non-affinity Purification of Proteins |
| LT1543038T (en) | 2002-09-11 | 2017-07-10 | Genentech, Inc. | Protein purification |
| GB0224082D0 (en) * | 2002-10-16 | 2002-11-27 | Celltech R&D Ltd | Biological products |
| AT412785B (en) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | GAG BINDING PROTEINS |
| US8067182B2 (en) * | 2005-03-11 | 2011-11-29 | Wyeth Llc | Method of weak partitioning chromatography |
| CN101437839A (en) * | 2006-03-20 | 2009-05-20 | 米德列斯公司 | Protein purification |
| SG10201406358SA (en) * | 2006-04-05 | 2014-12-30 | Abbvie Biotechnology Ltd | Antibody purification |
| US20080000431A1 (en) | 2006-06-29 | 2008-01-03 | Stephen Longo | Dog leash assembly |
| TWI448330B (en) | 2007-10-30 | 2014-08-11 | Genentech Inc | Antibody purification by cation exchange chromatography |
| WO2009135656A1 (en) * | 2008-05-06 | 2009-11-12 | Lonza Biologics Plc. | A method for the purification of antibodies using displacement chromatography |
| US20100111853A1 (en) * | 2008-10-20 | 2010-05-06 | Abbott Laboratories, Inc. | Antibodies that bind to il-12 and methods of purifying the same |
| CA2738499A1 (en) * | 2008-10-20 | 2010-04-29 | Abbott Laboratories | Viral inactivation during purification of antibodies |
| GB201012603D0 (en) * | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Protein purification |
-
2010
- 2010-07-27 GB GBGB1012603.5A patent/GB201012603D0/en not_active Ceased
-
2011
- 2011-07-26 US US13/812,654 patent/US9309280B2/en active Active
- 2011-07-26 CN CN201711066852.0A patent/CN107793477A/en active Pending
- 2011-07-26 SG SG10201802316VA patent/SG10201802316VA/en unknown
- 2011-07-26 PT PT117363648T patent/PT2598514T/en unknown
- 2011-07-26 CN CN2011800364214A patent/CN103025752A/en active Pending
- 2011-07-26 ES ES11736364T patent/ES2834967T3/en active Active
- 2011-07-26 SG SG2013001060A patent/SG186957A1/en unknown
- 2011-07-26 BR BR112013000623-4A patent/BR112013000623B1/en active IP Right Grant
- 2011-07-26 CA CA2805132A patent/CA2805132C/en active Active
- 2011-07-26 LT LTEP11736364.8T patent/LT2598514T/en unknown
- 2011-07-26 SI SI201131928T patent/SI2598514T1/en unknown
- 2011-07-26 RS RS20201356A patent/RS61095B1/en unknown
- 2011-07-26 AU AU2011284896A patent/AU2011284896B2/en active Active
- 2011-07-26 HU HUE11736364A patent/HUE052159T2/en unknown
- 2011-07-26 EP EP20182672.4A patent/EP3747893A1/en not_active Withdrawn
- 2011-07-26 JP JP2013521115A patent/JP5893622B2/en active Active
- 2011-07-26 KR KR1020137004824A patent/KR101921767B1/en active IP Right Grant
- 2011-07-26 EP EP11736364.8A patent/EP2598514B1/en active Active
- 2011-07-26 WO PCT/EP2011/062837 patent/WO2012013682A2/en active Application Filing
- 2011-07-26 PL PL11736364T patent/PL2598514T3/en unknown
- 2011-07-26 DK DK11736364.8T patent/DK2598514T3/en active
-
2012
- 2012-12-27 IL IL223931A patent/IL223931A/en active IP Right Grant
-
2015
- 2015-12-22 US US14/977,688 patent/US10189897B2/en active Active
-
2018
- 2018-05-08 HK HK18105961.4A patent/HK1246330A1/en unknown
-
2019
- 2019-01-16 US US16/248,845 patent/US11339214B2/en active Active
-
2020
- 2020-12-08 CY CY20201101160T patent/CY1123619T1/en unknown
-
2022
- 2022-05-23 US US17/750,444 patent/US20220289832A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1246330A1 (en) | Protein purification | |
| IL261147A (en) | Methods of purifying polypeptides | |
| HRP20181357T1 (en) | Novel protein purification methods | |
| HK1218558A1 (en) | Mirac proteins mirac | |
| IL221072A0 (en) | Single unit antibody purification | |
| EP2588129A4 (en) | Small-molecule-targeted protein degradation | |
| GB201012651D0 (en) | Peptides | |
| EP2619333A4 (en) | Native-extension parallel sequencing | |
| SG10201606218WA (en) | Purified Proteins | |
| ZA201300320B (en) | Purification process | |
| IL240134A0 (en) | Novel proteins | |
| ZA201109283B (en) | Protein | |
| EP2627674A4 (en) | Egfr-based peptides | |
| EP2521787A4 (en) | Enhanced protein expression | |
| GB0909384D0 (en) | Protein | |
| HUP1100282A2 (en) | Protein factor | |
| HU1000199V0 (en) | Turning unit |